Moderna, Inc. — Director's Dealing 2025

Oct 6, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2025-10-02

Reporting Person: Hussain Abbas (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-10-02	Common Stock	M	1439	—	Acquired	2019	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-10-02	Restricted Stock Units	$	M	1439	Disposed		Common Stock (1439)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: The shares subject to this restricted stock unit award vested in full on October 2, 2025.